医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

FDA Commissioner Among Top Global Regulators Attending DIA Annual Meeting

2014年05月02日 AM07:00
このエントリーをはてなブックマークに追加


 

WASHINGTON

Food and Drug Administration Commissioner Margaret A. Hamburg and top global regulators from Europe and Japan will tackle the challenges facing international drug and medical device regulators and the impact on therapies and patients at the DIA 2014 50th Annual Meeting in San Diego from June 15 to 19.

Hamburg and global regulators Guido Rasi, executive director of the European Medicines Agency, and Tatsuya Kondo, chief executive of Japan’s Pharmaceutical and Medical Devices Agency, will explore how the model of regulatory collaboration is evolving from traditional harmonization and information-sharing models to strategic coalitions and work-sharing initiatives. The first session in the two-part forum, “New Approaches to International Collaboration Between Regulators,” will be held June 16 from 8:30 to 10 a.m. at the San Diego Convention Center. Part two, featuring regulatory leaders from the U.S., Europe, Brazil, China and Switzerland, will follow at 11 a.m.

“Dr. Hamburg’s perspective is incredibly valuable to the DIA attendees in understanding the impacts of global regulatory challenges. We are grateful that she and the top international regulatory leaders are lending their voices and expertise to advancing regulatory science and ensuring safe and effective medical products are available to patients worldwide,” said Barbara L. Kunz, DIA global chief executive.

ABOUT DIA: DIA is the global connector in the life sciences product development process. Our association of more than 18,000 members builds productive relationships by bringing together regulators, innovators and influencers to exchange knowledge and collaborate in an impartial setting. DIA’s network creates unparalleled opportunities for the exchange of knowledge and has the interdisciplinary experience to prepare for future developments. DIA is an independent, nonprofit organization with its global center in Washington, D.C., USA, and regional offices covering North and South America (Horsham, Pa., USA); Europe, North Africa and the Middle East (Basel, Switzerland); and Japan (Tokyo), India (Mumbai) and China (Beijing). For more information, visit www.diahome.org.

ABOUT DIA’s 2014 50th ANNUAL MEETING: Celebrate the Past – Invent the Future is the largest multidisciplinary event that brings together a community of life sciences professionals at all levels and across all disciplines involved in the discovery, development and life cycle management of medical products. The meeting aims to foster innovation that will lead to the development of safe and effective medical products and therapies for patients. For more information, visit www.diahome.org/dia2014.

CONTACT

DIA
Tiffany Cohen, 202-499-4411
tcohen@reingold.com

同じカテゴリーの記事 

  • joimax® Obtains Registration for All Products in the Indian Market
  • Avistone Announces the Approval of Vebreltinib as the First MET-TKI Treatment for a Rare Brain Glioma Subtype in China
  • Inocras Pioneers Precision Health with Revolutionary Whole Genome Insights
  • エクセルゲン、バクスター・インターナショナルを提訴。口腔体温計の精度に関するデータの公表権を擁護
  • パース・バイオサイエンシズが研究室用自動化プロバイダー・プログラムをローンチし、ハミルトン、オープントロンズ、ラボワークス、SPTラボテックと提携